Get started
Work

Abstract CT152: Preliminary results from a phase II trial evaluating the safety and efficacy of JS207, a bispecific antibody targeting PD-1 and VEGF, in combination with chemotherapy in patients with metastatic colorectal cancer

Year: 2026
Type: conference-abstract
DOI: 10.1158/1538-7445.am2026-ct152
Authors: Yong Gao, Zhiwei Li, Jianwei Yang, Shuqing Jin, Yiyi Yu, Chang Wang, Xiwen Huang, Jingdong Zhang, Yanhong Gu, Shuqin Ni, Yanlai Sun, Shirong Cai, Liang Han, Xinjun Liang, Haichuan Su, Chenxi Wang, Zhenyu Xu, Jing Xu, Chengbo Jia, Jianjun Zou, Lin Shen
Institutions: Shanghai East Hospital, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University, Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Fudan University, Zhongshan Hospital, First Hospital of Jilin University, Junshi Biosciences (China), Meizhou City People's Hospital, Jiangsu Province Hospital, Shandong Tumor Hospital, Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University, Xuzhou Central Hospital, Hubei Cancer Hospital, Tang Du Hospital, Air Force Medical University, Peking University, Peking University Cancer Hospital
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7154718339
Cites:
Cited by:
Related to: